The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Circulating exosomal microRNAs as prognostic biomarkers for non-small-cell lung cancer
Open accessAbstract
// Qingyun Liu 1, * , Zubin Yu 2, * , Shuai Yuan 1, * , Weijia Xie 1 , Chengying Li 1 , Zeyao Hu 1 , Ying Xiang 1 , Na Wu 1 , Long Wu 1 , Li Bai 3, ** , Yafei Li 1, ** 1 Department of Epidemiology, College of Preventive Medicine, Third Military Medical University, Chongqing, People’s Republic of China 2 Department of Thoracic Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing, People’s Republic of China 3 Department of Respiratory Disease, Xinqiao Hospital, Third Military Medical University, Chongqing, People’s Republic of China * These authors have contributed equally to this work ** These authors jointly directed the project Correspondence to: Yafei Li, email: liyafei2008@hotmail.com Keywords: non-small-cell lung cancer (NSCLC), exosome, miRNAs, prognosis, biomarker Received: June 29, 2016 Accepted: December 05, 2016 Published: December 30, 2016 ABSTRACT Exosomal miRNAs are proposed as excellent candidate biomarkers for clinical applications. However, little is known about their potential roles as prognostic biomarkers in lung cancer. In this study, we explored the prognostic value of plasma exosomal microRNAs (miRNAs) for non-small-cell lung cancer (NSCLC). Using a quantitative polymerase chain reaction (qPCR) array panel, we analyzed 84 plasma exosomal miRNAs in 10 lung adenocarcinoma patients and 10 matched healthy controls. The qPCR array showed 30 aberrantly expressed exosomal miRNAs. Nine candidate miRNAs were selected based on differential expression and previous reports for further evaluating their prognostic roles in 196 NSCLC patients. Elevated levels of exosomal miR-23b-3p, miR-10b-5p and miR-21-5p were independently associated with poor overall survival (with hazard ratio [95% confidence interval]: 2.42 (1.45 - 4.04), P = 0.001; 2.22 (1.18 - 4.16), P = 0.013; 2.12 (1.28 - 3.49), P = 0.003, respectively). When compared to the clinical prognostic variables only model, adding the three exosomal miRNA signatures significantly improved survival predictive accuracy with an increase of time-dependent area under the receiver operating characteristic curve from 0.88 to 0.91 (P=0.015). Our results indicated that plasma exosomal miR-23b-3p, miR-10b-5p and miR-21-5p are promising non-invasive prognostic biomarkers of NSCLC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer
Taylor, D. D., & Gercel-Taylor, C. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.04.033 · Cited by 2,288
RetractedR: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,853
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Andersen, C. L., Jensen, J. L., & Ørntoft, T. F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0496 · Cited by 7,127
Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles
Colombo, M., Raposo, G., & Théry, C. (2014) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-101512-122326 · Cited by 6,186
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Exosomes: composition, biogenesis and function
Théry, C., Zitvogel, L., & Amigorena, S. (2002) · Nature Reviews Immunology · doi:10.1038/nri855 · Cited by 5,346
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Camp, R. L., Dolled-Filhart, M., & Rimm, D. L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0713 · Cited by 3,744
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET
Peinado, H., Alečković, M., Lavotshkin, S., Matei, I., Costa-Silva, B., Moreno-Bueno, G., Hergueta-Redondo, M., Williams, C., García-Santos, G., Ghajar, C. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2753 · Cited by 3,715
Rhodes, D. R., Kalyana-Sundaram, S., Mahavisno, V., Varambally, R., Yu, J., Briggs, B. B., Barrette, T. R., Anstet, M. J., Kincead-Beal, C., Kulkarni, P., et al. (2007) · Neoplasia · doi:10.1593/neo.07112 · Cited by 2,060
Non-small-cell lung cancers: a heterogeneous set of diseases
Chen, Z., Fillmore, C. M., Hammerman, P. S., Kim, C. F., & Wong, K.-K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3775 · Cited by 1,942
Blanche, P., Dartigues, J., & Jacqmin‐Gadda, H. (2013) · Statistics in Medicine · doi:10.1002/sim.5958 · Cited by 1,852
Optimized exosome isolation protocol for cell culture supernatant and human plasma
Lobb, R. J., Becker, M., Wen Wen, S., Wong, C. S. F., Wiegmans, A. P., Leimgruber, A., & Möller, A. (2015) · Journal of Extracellular Vesicles · doi:10.3402/jev.v4.27031 · Cited by 1,705
Double-stranded DNA in exosomes: a novel biomarker in cancer detection
Thakur, B. K., Zhang, H., Becker, A., Matei, I., Huang, Y., Costa-Silva, B., Zheng, Y., Hoshino, A., Brazier, H., Xiang, J., et al. (2014) · Cell Research · doi:10.1038/cr.2014.44 · Cited by 1,596
miRDeepFinder: a miRNA analysis tool for deep sequencing of plant small RNAs
Xie, F., Xiao, P., Chen, D., Xu, L., & Zhang, B. (2012) · Plant Molecular Biology · doi:10.1007/s11103-012-9885-2 · Cited by 1,536
Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
Rabinowits, G., Gerçel-Taylor, C., Day, J. M., Taylor, D. D., & Kloecker, G. H. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.006 · Cited by 1,262
The majority of microRNAs detectable in serum and saliva is concentrated in exosomes
Gallo, A., Tandon, M., Alevizos, I., & Illei, G. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030679 · Cited by 1,060
Characterization of human plasma-derived exosomal RNAs by deep sequencing.
Huang, X., Yuan, T., Tschannen, M., Sun, Z., Jacob, H., Du, M., Liang, M., Dittmar, R. L., Liu, Y., Liang, M., et al. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-319 · Cited by 932
Grange, C., Tapparo, M., Collino, F., Vitillo, L., Damasco, C., Deregibus, M. C., Tetta, C., Bussolati, B., & Camussi, G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0241 · Cited by 851
OncomiRs: the discovery and progress of microRNAs in cancers
Cho, W. C. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-60 · Cited by 719
Cheng, L., Sharples, R. A., Scicluna, B. J., & Hill, A. F. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.23743 · Cited by 715
Ono, M., Kosaka, N., Tominaga, N., Yoshioka, Y., Takeshita, F., Takahashi, R.-U., Yoshida, M., Tsuda, H., Tamura, K., & Ochiya, T. (2014) · Science Signaling · doi:10.1126/scisignal.2005231 · Cited by 696
Exosomal miR-1290 and miR-375 as Prognostic Markers in Castration-resistant Prostate Cancer
Huang, X., Yuan, T., Liang, M., Du, M., Xia, S., Dittmar, R., Wang, D., See, W., Costello, B. A., Quevedo, F., et al. (2015) · European Urology · doi:10.1016/j.eururo.2014.07.035 · Cited by 681
Exosomes and their roles in immune regulation and cancer
Greening, D. W., Gopal, S. K., Xu, R., Simpson, R. J., & Chen, W. (2015) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2015.02.009 · Cited by 597
Exosomes in bodily fluids are a highly stable resource of disease biomarkers
Boukouris, S., & Mathivanan, S. (2015) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201400114 · Cited by 586
Kogure, T., Lin, W.-L., Yan, I. K., Braconi, C., & Patel, T. (2011) · Hepatology · doi:10.1002/hep.24504 · Cited by 551
Syn, N., Wang, L., Sethi, G., Thiery, J.-P., & Goh, B.-C. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.04.006 · Cited by 478
Cazzoli, R., Buttitta, F., Di Nicola, M., Malatesta, S., Marchetti, A., Rom, W. N., & Pass, H. I. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318299ac32 · Cited by 452
Tanaka, Y., Kamohara, H., Kinoshita, K., Kurashige, J., Ishimoto, T., Iwatsuki, M., Watanabe, M., & Baba, H. (2013) · Cancer · doi:10.1002/cncr.27895 · Cited by 446
Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer
Singh, R., Pochampally, R., Watabe, K., Lu, Z., & Mo, Y.-Y. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-256 · Cited by 399
Exosomal Tumor MicroRNA Modulates Premetastatic Organ Cells
Rana, S., Malinowska, K., & Zöller, M. (2013) · Neoplasia · doi:10.1593/neo.122010 · Cited by 346
Momen-Heravi, F., Saha, B., Kodys, K., Catalano, D., Satishchandran, A., & Szabo, G. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0623-9 · Cited by 307
Ostenfeld, M. S., Jeppesen, D. K., Laurberg, J. R., Boysen, A. T., Bramsen, J. B., Primdal-Bengtson, B., Hendrix, A., Lamy, P., Dagnaes-Hansen, F., Rasmussen, M. H., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3512 · Cited by 294
Shi, R., Wang, P.-Y., Li, X.-Y., Chen, J.-X., Li, Y., Zhang, X.-Z., Zhang, C.-G., Jiang, T., Li, W.-B., Ding, W., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4699 · Cited by 285
Self-citationGao, W., Yu, Y., Cao, H., Shen, H., Li, X., Pan, S., & Shu, Y. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.01.018 · Cited by 251
Formation and role of exosomes in cancer
Brinton, L. T., Sloane, H. S., Kester, M., & Kelly, K. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1764-3 · Cited by 244
Reproducibility and efficiency of serum-derived exosome extraction methods
Caradec, J., Kharmate, G., Hosseini-Beheshti, E., Adomat, H., Gleave, M., & Guns, E. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.06.011 · Cited by 243
Claudin-containing exosomes in the peripheral circulation of women with ovarian cancer
Li, J., Sherman-Baust, C. A., Tsai-Turton, M., Bristow, R. E., Roden, R. B., & Morin, P. J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-244 · Cited by 241
Yang, M., Shen, H., Qiu, C., Ni, Y., Wang, L., Dong, W., Liao, Y., & Du, J. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.09.031 · Cited by 226
Kobayashi, M., Salomon, C., Tapia, J., Illanes, S. E., Mitchell, M. D., & Rice, G. E. (2014) · Journal of Translational Medicine · doi:10.1186/1479-5876-12-4 · Cited by 225
Corcoran, C., Rani, S., & O'Driscoll, L. (2014) · The Prostate · doi:10.1002/pros.22848 · Cited by 223
Genome-wide functional screening of miR-23b as a pleiotropic modulator suppressing cancer metastasis
Zhang, H., Hao, Y., Yang, J., Zhou, Y., Li, J., Yin, S., Sun, C., Ma, M., Huang, Y., & Xi, J. J. (2011) · Nature Communications · doi:10.1038/ncomms1555 · Cited by 201
The role of exosomes and “exosomal shuttle microRNA” in tumorigenesis and drug resistance
Zhao, L., Liu, W., Xiao, J., & Cao, B. (2015) · Cancer Letters · doi:10.1016/j.canlet.2014.10.027 · Cited by 167
Ouyang, H., Gore, J., McElyea, S. D., & Korc, M. (2013) · Oncogene · doi:10.1038/onc.2013.405 · Cited by 159
Circulating melanoma exosomes as diagnostic and prognosis biomarkers
Alegre, E., Zubiri, L., Perez‐Gracia, J. L., González‐Cao, M., Soria, L., Martín‐Algarra, S., & González, Á. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.12.031 · Cited by 157
Majid, S., Dar, A. A., Saini, S., Arora, S., Shahryari, V., Zaman, M. S., Chang, I., Yamamura, S., Tanaka, Y., Deng, G., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2181 · Cited by 151
YKT6 expression, exosome release, and survival in non-small cell lung cancer
Ruíz-Martínez, M., Navarro, A., Marrades, R. M., Viñolas, N., Santasusagna, S., Muñoz, C., Ramírez, J., Molins, L., & Monzó, M. (2016) · Oncotarget · doi:10.18632/oncotarget.9862 · Cited by 138
Dinh, T.-K. T., Fendler, W. M., Chałubińska‐Fendler, J., Acharya, S. S., O’Leary, C., Deraska, P. V., D’Andrea, A. D., Chowdhury, D., & Kozono, D. (2016) · Radiation Oncology · doi:10.1186/s13014-016-0636-4 · Cited by 122
Goto, Y., Kojima, S., Nishikawa, R., Enokida, H., Chiyomaru, T., Kinoshita, T., Nakagawa, M., Naya, Y., Ichikawa, T., & Seki, N. (2014) · Oncotarget · doi:10.18632/oncotarget.2294 · Cited by 118
Taverna, S., Giallombardo, M., Bazo, I. G., Carreca, A. P., Castiglia, M., Chacartegui, J. J., Araújo, A., Alessandro, R., Pauwels, P., Peeters, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7638 · Cited by 114
Li, Y., Zhang, L., Liu, F., Xiang, G., Jiang, D., & Pu, X. (2015) · Disease Markers · doi:10.1155/2015/893594 · Cited by 107
Self-citationExosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment
Srivastava, A., Filant, J., Moxley, K. M., Sood, A. K., McMeekin, S., & Ramesh, R. (2015) · Current Gene Therapy · doi:10.2174/1566523214666141224100612 · Cited by 95
Chiyomaru, T., Seki, N., Inoguchi, S., ISHIHARA, T., Mataki, H., Matsushita, R., Goto, Y., Nishikawa, R., Tatarano, S., Itesako, T., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2752 · Cited by 87
Serum miR-21 level: a potential diagnostic and prognostic biomarker for non-small cell lung cancer.
Zhao, W., Zhao, J.-J., Zhang, L., Xu, Q.-F., Zhao, Y., Shi, X.-Y., & Xu, A. (2015) · PubMed · Cited by 73
Huang, J., Sun, C., Wang, S., He, Q., & Li, D. (2015) · Molecular BioSystems · doi:10.1039/c4mb00752b · Cited by 62
Ell, B. J., Qiu, Q., Wei, Y., Mercatali, L., Ibrahim, T., Amadori, D., & Kang, Y. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.582866 · Cited by 61
Giallombardo, M., Chacartegui, J. J., Castiglia, M., Steen, N. V. D., Mertens, I., Pauwels, P., Peeters, M., & Rolfo, C. D. (2016) · Journal of Visualized Experiments · doi:10.3791/53900 · Cited by 60
Capodanno, A., Boldrini, L., Proietti, A., Alì, G., Pelliccioni, S., Niccoli, C., D’Incecco, A., Cappuzzo, F., Chella, A., Lucchi, M., et al. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.2003 · Cited by 59
Li, Y., Xiang, G., Liu, L., Liu, C., Liu, F., Jiang, D., & Pu, X. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3919 · Cited by 56
Self-citationCinegaglia, N., Andrade, S. C. S., Tokár, T., Pinheiro, M., Severino, F. E., de Oliveira, R. A., Hasimoto, É. N., Catâneo, D. C., Catâneo, A. J. M., Defaveri, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8713 · Cited by 48
Regulation of miR-23b expression and its dual role on ROS production and tumour development
Donadelli, M., Dando, I., Fiorini, C., & Palmieri, M. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.04.012 · Cited by 47
Decreased Expression of MicroRNA-375 in Nonsmall Cell Lung Cancer and its Clinical Significance
Li, Y., Jiang, Q., Xia, N., Yang, H., & Hu, C. (2012) · Journal of International Medical Research · doi:10.1177/030006051204000505 · Cited by 43
Self-citationBegum, S., Hayashi, M., Ogawa, T., Jabboure, F. J., Brait, M., Izumchenko, E., Tabak, S., Ahrendt, S. A., Westra, W. H., Koch, W. M., et al. (2015) · Scientific Reports · doi:10.1038/srep13236 · Cited by 35
Cited by
Doyle, L., & Wang, M. (2019) · Cells · doi:10.3390/cells8070727 · Cited by 3,236
Extracellular vesicles in cancer — implications for future improvements in cancer care
Xu, R., Rai, A., Chen, M., Suwakulsiri, W., Greening, D. W., & Simpson, R. J. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0036-9 · Cited by 1,445
miRNAs as Biomarkers in Disease: Latest Findings Regarding Their Role in Diagnosis and Prognosis
Condrat, C. E., Thompson, D. C., Barbu, M. G., Bugnar, O. L., Boboc, A., Cretoiu, D., Suciu, N., Cretoiu, S. M., & Voinea, S. C. (2020) · Cells · doi:10.3390/cells9020276 · Cited by 1,344
Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments
Lone, S. N., Nisar, S., Masoodi, T., Singh, M., Rizwan, A., Hashem, S., El-Rifai, W., Bedognetti, D., Batra, S. K., Haris, M., et al. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01543-7 · Cited by 819
Effect of exosomal miRNA on cancer biology and clinical applications
Sun, Z., Shi, K., Yang, S., Liu, J., Zhou, Q., Wang, G., Song, J., Li, Z., Zhang, Z., & Yuan, W. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0897-7 · Cited by 800
Metadata
- Authors
- Liu, Q., Yu, Z., Yuan, S., Xie, W., Li, C., Hu, Z., Xiang, Y., Wu, N., Wu, L., Bai, L., & Li, Y.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-12-30
- Volume
- 8
- Issue
- 8
- Pages
- 13048-13058
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2564567999
- Cited by
- 258
- References
- 65
- FWCI
- 10.53
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.